| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Executive Officer
1 company
Richard Nolan Townsend is Chief Executive Officer at LXEO. From January 2024 to September 2026, the filings on record show 0 open-market purchases and 18 sales. Richard Nolan Townsend's net worth is not public. Form 4 filings only show shares in the companies where this person is an insider; those holdings are worth an estimated $1.2M at current prices.
Our model assigns Richard Nolan Townsend a strong insider score of 74/100, based on 18 past trades. Over a 12-month horizon, 53.8% of those trades were profitable, with an average 12-month return of +27.1%.
The LXEO filings lean toward selling, a net 205,202 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec 10, 2024 | LXEO Lexeo Therapeutics, Inc. | Chief Executive Officer | Sale+OE10b5-1 | 2,500 | $8.20 | $20,491.25 | -2.0% | -68.7% | +16.4% | |
| Nov 11, 2024 | LXEO Lexeo Therapeutics, Inc. | Chief Executive Officer | Sale+OE10b5-1 | 2,500 | $7.82 | $19,556.75 | -2.0% | -41.9% | +14.7% | |
| Oct 10, 2024 | LXEO Lexeo Therapeutics, Inc. | Chief Executive Officer | Sale+OE10b5-1 | 5,000 | $8.10 | $40,495.50 | -4.0% | -14.3% | +3.5% | |
| Sep 10, 2024 | LXEO Lexeo Therapeutics, Inc. | Chief Executive Officer | Sale+OE10b5-1 | 5,000 | $10.65 | $53,273.50 | -4.0% | -19.9% | -49.8% | |
| Aug 12, 2024 | LXEO Lexeo Therapeutics, Inc. | Chief Executive Officer | Sale+OE10b5-1 | 5,000 | $11.53 | $57,634.50 | -4.0% | -33.6% | -61.0% | |
| Jul 11, 2024 | LXEO Lexeo Therapeutics, Inc. | Chief Executive Officer | Sale+OE10b5-1 | 55,000 | $16.79 | $923,387.71 | -31.3% | -51.3% | -74.4% | |
| Jun 10, 2024 | LXEO Lexeo Therapeutics, Inc. | Chief Executive Officer | Sale+OE10b5-1 | 5,000 | $17.65 | $88,263.82 | -2.8% | -42.2% | -75.4% | |
| May 13, 2024 | LXEO Lexeo Therapeutics, Inc. | Chief Executive Officer | Sale+OE10b5-1 | 5,000 | $13.22 | $66,093.00 | -2.8% | -11.7% | -79.1% |